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Abstract
Background: Polypharmacy is common among older people. The purpose of this study is to describe GPs’ views
and beliefs on polypharmacy in order to identify the role of the GP in relation to improving prescribing behaviour.
The awareness of these often established beliefs is key for understanding behaviour and promoting change which
can guide action towards more rational prescribing.
Methods: A qualitative descriptive methodology was used with semi-structured interviews. Interviews were
conducted with 65 GPs from the region of Aalst, a district of a mixed urban and rural population in Belgium. The
aim of the study was to describe the GPs’ perspectives on polypharmacy in primary care.
Results: GPs acknowledge that polypharmacy is a problem in their older patient population, especially because of
the risk of adverse drug reactions, interactions and lowered adherence. GPs mention that difficulties in keeping an
overview of the exact medication intake is an important problem caused by polypharmacy. The patients’ strong
belief in their medication and self-medication are seen as important barriers in reducing the number of drugs
taken. Next to these patient related factors, there are some factors related to the prescriber, such as the lack of
regular evaluation of the medication schedule by GPs and the involvement of several prescribers, especially in a
hospital setting. According to the respondents, prevention and evidence based medicine guidelines often induce
polypharmacy.
Conclusions: GPs point out that polypharmacy is an important problem in their older patient population. They see
an important role for themselves in optimizing drug regimens for their patients. However, they do not have a
readymade solution for polypharmacy. The limited set of options for addressing polypharmacy leave GPs feeling
powerless to tackle the problem. There is a need for simple GP friendly tools and access to pharmacotherapeutic
advice. Future research in this area and interventions seeking to improve prescribing for the elderly will have to
focus on practical tools and take into account the GPs’ sense of helplessness.
Background
Polypharmacy
Prescribing medication is becoming more difficult and
complex. The inherent risk of adverse reactions and
interactions rises because of the pharmacological com-
plexity of modern drugs, the ageing population, and the
increasing polypharmacy [1]. Polypharmacy can be
defined as the concomitant use of 3 or more drugs [2]
or the use of more drugs than indicated. Polypharmacy
is particularly common among older adults - around
20% of people over 70 in the Western World are taking
five or more drugs [3]. Although appropriate medication
can reduce symptoms, morbidity and mortality in older
patients, drugs can also be dangerous. Polypharmacy
increases the risk of having adverse drug reactions and/
or interactions, it also means that unnecessary drugs
may be obscured by the large number of necessary ones
[4-7]. The risk for reduced adherence to the prescribed
regimen increases as the number of prescribed medica-
tions increases [8,9]. In older adults, between 10% and
20% of hospital admissions are drug related [5].
The role of the general practitioner
Even though the general practitioner (GP) is not always
the prescriber, most patients have a longstanding rela-
tionship with their GP. Moreover, the GP is ideally
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placed to have a global overview of the medication
intake of his/her patient. Many quantitative studies have
identified deficiencies in the use and prescription of
medication, yet, there are few qualitative investigations
on the views of general practitioners (GPs) on polyphar-
macy. Understanding processes and mechanisms of
underlying behaviour is vital in achieving behaviour
change [10].
Purpose of the study
The purpose of this study is to describe GPs’ views and
beliefs on polypharmacy in order to identify the role of
the GP in relation to improving prescribing behaviour.
The awareness of these often established beliefs is one
of the most important drivers for change as it can guide
the action needed for more rational prescribing.
Methods
Study design
A qualitative descriptive methodology [11] was used to
explore the views of GPs on polypharmacy in order to
establish a comprehensive summary of events in every-
day terms with the aim of developing a description of
the views of GPs towards polypharmacy.
Individual semi-structured interviews were used to
explore the perspectives of general practitioners, as they
are particularly useful when discussing sensitive issues
like polypharmacy. Data collection by semi-structured
interviews allows participants to be asked questions
within a flexible framework [12]. The study was
approved by the ethics committee of the Ghent Univer-
sity Hospital and written informed consent was obtained
from all respondents.
Participants
The study was conducted in the district of Aalst (a city
of 80 000 inhabitants with two hospitals; a poor central
population and rich residential quarters as well as rural
residents). All 102 GPs from a list of GPs from Aalst
were contacted by letter and invited to participate in the
study. After a week they were contacted by telephone
and 65 GPs agreed to be interviewed at their practice.
The purposeful maximum variation sample [13] of 65
general practitioners (40 men and 25 women) with an
average age of 50 years reflected a wide variety in terms
of experience and location (city and rural).
The research team developed a semi-structured inter-
view guide after a preliminary review of the literature.
The interview guide consisted of the following broad
topic sections: reflections on polypharmacy in general
practice; factors contributing to polypharmacy in general
practice; reflections on GPs’ specific role and their atti-
tudes to interventions to optimize prescribing. Within
each broad section of the interview topic guide there
were more detailed questions and specific probes to
allow the discussion to develop (Table 1). After each
interview, the interviewers completed a debriefing to
discuss relevant contextual information, general impres-
sions of the interview, and possible changes to the inter-
view guide. Audiotapes of each interview were
transcribed verbatim.
Data analysis
We used a qualitative content analysis [14,15] which is a
good method in qualitative descriptive methodology [11]
orientated towards summarizing the informational content
of the data. The interviews were read by two researchers
(SA & AT) to become familiar with the data. The text
about the views of the GPs on polypharmacy was then
extracted by two independent coders and brought together
as a unit of analysis and labelled with different codes by
first highlighting the exact words from the text that
appeared to capture key thoughts. The various codes were
compared and sorted into categories. Finally, the underly-
ing meaning was formulated into themes after discussion
with the different research members.
Rigour of the study
The research team used several methods to ensure the
study was rigorous and trustworthy. Audio-taped and
written verbatim versions of the interviews were com-
pared to ensure accuracy and completeness of data.
Debriefing and field notes were maintained and
reviewed by team members.
Results
On the whole GPs acknowledge that polypharmacy is a
problem in their older patient population and a major
challenge for general practice. The data show that the
respondents identify 4 themes that influence polyphar-
macy, namely patient related, GP related, evidence based
medicine (EBM) and specialist related factors.
Patient related factors influencing polypharmacy
according to the GPs
Being the major consumers, older adults are particularly
vulnerable to adverse drug reactions.
“With older age, you have to take into account that
organs are not working properly anymore.” (36) “The
chance of side effects of medication in this older age
group is also much higher: kidney function is not as good
anymore and then you start treating side effects...” (20)
Side effects are not always recognized as such. They
can be very pronounced in this population and this can
lead to a pharmacological treatment of side effects or
even to hospital admission.
GPs acknowledge the difficulty in keeping an overview
of the exact intake of medication of their older patients.
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When older adults have to take a lot of drugs, the dan-
ger of self medication exists - patients change their own
regimens by discontinuing them, lowering, increasing or
skipping doses without consulting their GP.
“...sometimes the older people decide for themselves to
reduce some of their medication or to adjust the doses
without telling their GP. Therefore as their GP you can
have the wrong impression about their medication
intake...” (28)
The risk of this is that GPs prescribe additional drugs
as it seems the previous doses are not having the
expected effect. Therefore GPs place a lot of emphasis
on the importance of compliance.
Patients are not always inclined to stop using drugs
that they have used for a long time. Some patients can
be demanding and difficult when their use of medication
is questioned and resist any attempt to change their
prescriptions:
“A lot of medication that has once been prescribed is
being taken daily. The patient feels fine and does not
want to change the medication regime” (38)
Most GPs recognize a very strong attachment in many
patients to benzodiazepines or pain medication whilst
they also acknowledge that these are some of the drugs
that should be avoided or reduced.
GPs perceive self-medication as a real problem. The
GP is not the only provider, the older people often
receive medication from friends, relatives or from neigh-
bours. They do not perceive this as their prescribed
medication and consequently, they do not take into
account the possible side effects or interactions:
“They take a blood-diluting drug. Then they take
another aspirin with another brand name because their
neighbour told them that they should take one daily.
They have no idea what they are taking...” (31)
The role of GP related factors and its influence on
polypharmacy & suggested solutions
GPs refer to polypharmacy as a slowly growing process
and because of that they do not pay sufficient attention
to this phenomenon. It is easy to start a new treatment
for every new complaint without really evaluating the
existing medication schedule. They do find that they are
not critical enough. This routine approach might be one
of the factors that make polypharmacy so common.
Patients keep on taking their prescribed medication
(they feel good about it), whilst none is stopped or re-
evaluated:
“The number of medications grows slowly. There is a
complaint, we give new medication, it continues without
really stopping it after a while...and it is our responsibil-
ity to try and withdraw it from the patient..."(43)
GPs feel strongly that their role is as a ‘gatekeeper’
whose responsibility is to control the type and quantity
of medication used. They mention that established rou-
tines for assessing the total medication schedule of the
patient are necessary.
GPs feel they should take the initiative to prescribe
only the essential medication and to lower doses. They
also realise it is not necessary to treat every single symp-
tom but to look at the overall health status of their
patient and the quality of life. GPs suggest that a list of
priority medication in order of importance might be
very helpful. The respondents mention that it is essen-
tial to be alert at every single consultation. For every
prescription renewal they should ask themselves
whether the medication is still necessary and if not they
should stop the prescribed medicine.
The role of evidence based medicine in polypharmacy
according to the GPs
GPs feel under pressure from guidelines to prescribe
preventive drugs, even though the negative impacts of
polypharmacy may outweigh the possible benefits from
individual drugs:
“If you want to follow the evidence based guidelines
then you need to work preventively. Then quickly you
will come to six additional medications..."(36) “ If you
look at the guidelines on what to prescribe post-infarct...
Strictly speaking that is 6 additional drugs...You will
have to draw a line between what is scientifically proven
and what is realistic in daily practice...” (49).
Table 1 Interview Questions
Broad Questions
What are your views on polypharmacy in general practice?
In your opinion, can something be done in order to reduce polypharmacy?
What could be a specific role for a GP in relation to polypharmacy and prescribing?
Specific Questions and Prompts
What are important factors contributing to polypharmacy?
Are there negative things about polypharmacy?
Do you think prescribing practices have changed over time?
Are there specific barriers that you can think of in order to reduce polypharmacy?
Are there specific elements that could help reduce polypharmacy? (types of interventions, education, ...)
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GPs are aware of the increased risk of interactions.
They should be alert to this but they admit it is difficult
to keep an overview when there is polypharmacy. GPs
report difficulties in differentiating between medical
conditions or symptoms due to side effects of
medication.
They also experience shortcomings in their pharmaco-
logical knowledge. The information available is not
always that accurate or up-to-date:
“We do not always have an overview of the interac-
tions, that is a big problem, firstly there is not much
information available for us GPs, and secondly when
there is information available to us it does not mean
that we know it; it is not that simple...” (26)
The role of increased specialization in health care and its
influence on polypharmacy
One of the reasons why GPs find polypharmacy a com-
plicated issue is that often more than one prescriber is
involved. Inappropriate prescribing can arise from the
absence of communication between doctors practising
in different settings or even between specialists practis-
ing in the same setting. Older adults often have several
chronic conditions and need several drugs; they are
often admitted to hospital and should have regular
reviews of their treatment.
GPs see a role for themselves to protect the patient
through regular follow-up.
“The GP has a holistic view of the patient. A specialist
often does not have the time to speak with the patient
about the entire medication regime. The GP can contact
the specialist...The coordination of the medication regime
of different disciplines is a tough job...” (12)
When the patient has been admitted to hospital it is
important to re-evaluate the medication schedule. GPs
find it important to have a coordinating role. They have
a holistic view of the patient because of the long stand-
ing doctor-patient relationship. This is in contrast to a
specialist who only looks at the patient from his or her
own discipline. This is perceived as a very tough job for
GPs with major implications for their workload:
“As a GP you have a broader view of your patient. You
look at him/her from his own life. Specialists narrow the
things down a little bit. I think it’s very important that
there is one coordinator who watches out over the
patient and sees that the pneumologist does not prescribe
something that can affect the cardiologic state of the
patient....” (41)
Discussion
This study highlights some of the GPs’ perceptions and
beliefs on polypharmacy. The perceptions of this
important group of prescribers on one of the main pro-
blem areas contributing to polypharmacy have not been
investigated until now. As the respondents in our study
remark, the primary care setting is seen as ideal for
addressing the problem of inappropriate prescribing,
this is in concordance with the literature [16]. Primary
care physicians are ideally placed to optimize drug regi-
mens given their knowledge of patient-specific informa-
tion and their ability to coordinate the patient’s overall
medical care [16].
Despite the GPs’ recognition that polypharmacy is a
problem in their older patient population and the fact
that GPs perceive it as their role in addressing the pro-
blem, they feel largely helpless to tackle it. GPs do not
have a ‘ready-made’ solution for polypharmacy.
It is important to point out that GPs experience obsta-
cles at different levels. One of the barriers is at the level
of the patient. The GPs believe that patients have a joint
responsibility. In their view the best option to achieve
medication reduction is to reduce drugs that are used
without a clear indication. Patients on the other hand
are not always inclined to stop taking medication that
they have been using chronically [17]. This is a well
known problem as for example in regard to other drugs
such as hypnotics [18]. Improvement of knowledge
alone may not solve the problem for GPs. They need
skills and tools to strengthen their confidence as GPs
perceive it as difficult to motivate patients to withdraw
from their medication. Motivational strategies may be
an important educational tool for GPs or community
nurses and even for pharmacists.
Medication compliance is inversely correlated with
number of drugs taken [8,9]. According to the GPs’ opi-
nion compliance and stimulation of compliance is one
of the most important challenges.
GPs also point out that older people are particular
vulnerable to adverse drug reactions, which are often
preventable [19]. Our participants do not refer to speci-
fic strategies to reduce adverse drug effects, however
other researchers have designed screening tools to
detect prescribing that is potentially inappropriate.
Examples of such screening tools are the Beers’ criteria
[20], the improving prescribing in the elderly, the
screening tool to help guide doctors towards the right
treatment (START) [19], NO TEARS [21] and ACOVE
[22]. Unfortunately these tools are not very useful or
practical for routine clinical screening as they are too
time consuming and too complex. Further research is
underway for new tools that are easier to use in primary
care [19]. There is a need for simple approaches such as
working in close collaboration with skilled pharmacists
or peers for ‘medication review’[23].
Another barrier is at the level of management. GPs
also talk about their own contribution to polypharmacy.
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They find that they are often not critical enough when
starting a new treatment. They see an important role for
themselves in controlling the type and quantity of medi-
cation used.
Many respondents bring up EBM guidelines as some-
thing which encourages polypharmacy. This is also
described in the literature [18,24,25]. A combination of
different drugs is often suggested as the ‘golden stan-
dard’ for treating a disease. There is more and more
emphasis on giving medication as a way of preventing
diseases. For older people preventive aims are often
minimal considering their age and polypathology, which
is in contrast with guidelines talking about one specific
disease. The disadvantage sometimes does not outweigh
the gain of taking medication.
The respondents in this study mention a lack of phar-
macological knowledge. There is a lack of adequate
training of doctors in geriatric pharmacotherapy [26]. In
literature several strategies have been tested to optimise
prescribing such as educational approaches, computer
assisted approaches, a medication review by clinical
pharmacists, geriatric medicine services, multidisciplin-
ary approaches and multifaceted approaches [23,27].
Yet, despite the substantial resources devoted to devel-
oping and testing the effectiveness of interventions to
improve prescribing, widespread diffusion of successful
methods has not yet been achieved [23]. When aiming
at setting up interventions for GPs, one has to be aware
that updating knowledge and information alone is not
enough. There is a need for a change in attitude and
behaviour of GPs and they need tools for this.
Most prescribing is done by the patient’s GP, but
medication is often started or adjusted in secondary
care. In Belgium and in other European countries spe-
cialists can work relatively independently without refer-
ral from GPs [28]. A recent study in the US found that
the incidence of adverse drug reactions is directly
related to the number of doctors prescribing [29]. The
findings also showed the reluctance of GPs to interfere
with treatment prescribed by a colleague as one of the
reasons mentioned for polypharmacy this has also been
found in previous research [26]. Therefore good com-
munication between GP and hospital, GP and patient
and GP and carers is crucial [7].
Conclusions
GPs point out that polypharmacy is an important problem
in their older patient population. They see an important
role for themselves in optimizing drug regimens for their
patients. However, they do not have a readymade solution
for polypharmacy. The limited set of options for addres-
sing polypharmacy leave GPs feeling powerless to tackle
the problem. There is a need for simple GP friendly tools
and access to pharmacotherapeutical advice. Future
research in this area and interventions seeking to improve
prescribing for the elderly will have to focus on practical
tools and take into account the GPs’ sense of helplessness.
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